Literature DB >> 15270838

Interference with immune function by HTLV-1.

P K C Goon1, C R M Bangham.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15270838      PMCID： PMC1809127          DOI： 10.1111/j.1365-2249.2004.02524.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  35 in total

1.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.

Authors:  S L Welles; N Tachibana; A Okayama; S Shioiri; S Ishihara; K Murai; N E Mueller
Journal:  Int J Cancer       Date:  1994-02-01       Impact factor: 7.396

3.  Crusted (Norwegian) scabies as a pre-diagnostic indicator for HTLV-1 infection.

Authors:  H Daisley; W Charles; M Suite
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 May-Jun       Impact factor: 2.184

4.  Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan.

Authors:  Y Sato; Y Shiroma; S Kiyuna; H Toma; J Kobayashi
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jan-Feb       Impact factor: 2.184

5.  Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.

Authors:  P G Fallon; E J Richardson; G J McKenzie; A N McKenzie
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.

Authors:  R C Newton; P Limpuangthip; S Greenberg; A Gam; F A Neva
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

7.  Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Anna Barfield; Amanda L Barnard; Lambrini Kaftantzi; Yuetsu Tanaka; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.

Authors:  R D Robinson; J F Lindo; F A Neva; A A Gam; P Vogel; S I Terry; E S Cooper
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

9.  Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan.

Authors:  O Kashala; R Marlink; M Ilunga; M Diese; B Gormus; K Xu; P Mukeba; K Kasongo; M Essex
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205
View more
  5 in total

1.  Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.

Authors:  Ana Laura Fazio; Wesley Kendle; Kimson Hoang; Erica Korleski; Isabelle Lemasson; Nicholas Polakowski
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP.

Authors:  Bárbara Brasil Santana; Maria Alice Freitas Queiroz; Rodrigo Arcoverde Cerveira; Claudia Mendonça Rodrigues; Ednelza da Silva Graça Amoras; Carlos Araújo da Costa; Maisa Silva de Sousa; Ricardo Ishak; Luiz Ricardo Goulart; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2021-02-25       Impact factor: 3.090

3.  Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).

Authors:  Md Thosif Raza; Shagufta Mizan; Farhana Yasmin; Al-Shahriar Akash; Shah Md Shahik
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

Review 4.  HTLV-1 and Co-infections.

Authors:  Carolina Rosadas; Graham P Taylor
Journal:  Front Med (Lausanne)       Date:  2022-02-03

5.  Familial transmission of human T-cell lymphotrophic virus: silent dissemination of an emerging but neglected infection.

Authors:  Carlos Araujo da Costa; Karen Cristini Yumi Ogawa Furtado; Louise de Souza Canto Ferreira; Danilo de Souza Almeida; Alexandre da Costa Linhares; Ricardo Ishak; Antonio Carlos Rosário Vallinoto; José Alexandre Rodrigues de Lemos; Luisa Caricio Martins; Edna Aoba Yassui Ishikawa; Rita Catarina Medeiros de Sousa; Maísa Silva de Sousa
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.